IP Library › Granted Patent US 10,557,135
Granted Patent B2
US 10,557,135 · App. 15/803,687 · Granted Feb 11, 2020

Sequence tags

Inventors: Frank Bergmann (Iffeldorf, DE); Bruno Frey (Penzberg, DE); Dieter Heindl (Munich, DE)
Assignee: Roche Sequencing Solutions, Inc.
C12N15/1065C12Q1/6806C12Q1/6848C12Q1/6853C12Q1/6855C12Q1/6869C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,557,135
App. No.
15/803,687
Granted
Feb 11, 2020
Kind
B2
Abstract

Provided herein is a new class of nucleic acid tagging molecules which are essentially free of homopolymer stretches. The tagging molecules can tag a plurality of individual target molecules for detection with a high degree of accuracy. The tagging molecules can be used to tag at least 10 5 or 10 6 individual target molecules. The tagged individual target molecules can be subjected to high throughput sequence analysis.

Claims (10)

1. A mixture comprising a plurality of oligonucleotides, each of said plurality of oligonucleotides comprising a degenerated sequence segment, wherein said plurality of oligonucleotides:

a. comprises at least 10 5 individual molecules;

b. does not comprise a representative with a homopolymer stretch longer than 3 nucleotide residues in the degenerated sequence segment,

wherein said degenerated sequence segment comprises one subsegment or more than one identical subsegments, wherein the subsegment has a sequence X1-X2-X3-X4, wherein X1 is a degenerated base region comprising a first set of three different bases or base analogs, X2 is a degenerated base region comprising a second set of three different bases or base analogs, X3 is a degenerated base region comprising a third set of three different bases or base analogs, and X4 is a degenerated base region comprising a fourth set of three different bases or base analogs, wherein said first, second, third and fourth sets are different from each other.

2. The mixture of claim 1 , wherein each of the plurality of oligonucleotides comprises at least 2 subsegments.

3. The mixture of claim 2 , wherein each of the plurality of oligonucleotides comprises at least 2 identical subsegments.

4. A method for tagging individual nucleic acid molecules, comprising the steps of providing a plurality of individual nucleic add molecules, adding the mixture of claim 1 , attaching one representative of said plurality of oligonucleotides to one representative each of said plurality of individual molecules.

5. The method according to claim 4 , wherein attaching comprises ligating the one representative of said plurality of oligonucleotides to the one representative of said plurality of individual molecules.

6. The method according to claim 4 , wherein said attaching comprises hybridizing a target binding site located downstream of said degenerated sequence segment to the plurality of individual molecules.

7. The method according to claim 6 , further comprising the step of elongating said plurality of individual oligonucleotides by means of performing a target dependent DNA polymerase catalyzed primer extension reaction.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2017
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 044139/0804 →
Priority Claims (1)
EP 13158348 · Mar 8, 2013 · regional
Continuity (2)
Division 14200325 · Mar 7, 2014
Related Publication 20180057811A1 · Mar 1, 2018